Ozempic helps patients eat less by slowing digestion, but excessive gastric emptying delays may create a hidden nutritional risk. Learn how severe fullness, nausea, and food intolerance can contribute to malnutrition during GLP-1 therapy.
Ozempic commonly causes nausea, fullness, and appetite suppression, but similar symptoms can also occur with gastroparesis. Learn the warning signs that help distinguish routine digestive side effects from a potentially serious gastric emptying disorder.
GLP-1 medications such as Ozempic and Wegovy intentionally slow digestion, but in rare cases this effect can progress to gastroparesis. Learn how to recognize warning signs, understand risk factors, and know when medical evaluation is necessary.